Clinical Trial Update: Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the PET imaging agent 18F-Clofarabine to measure deoxycytidine kinase activity in patients with metastatic cancer, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Cancer
• Carcinoma

Drugs mentioned

• 18F-Clofarabine (18F-clofarabine radiotracer)

Snippet

Sponsor: Roberto Vargas | Conditions: Metastatic Cancer, Carcinoma | EARLY_Phase 1 | Status: RECRUITING